1. Home
  2. DGX vs PODD Comparison

DGX vs PODD Comparison

Compare DGX & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGX
  • PODD
  • Stock Information
  • Founded
  • DGX 1967
  • PODD 2000
  • Country
  • DGX United States
  • PODD United States
  • Employees
  • DGX N/A
  • PODD N/A
  • Industry
  • DGX Medical Specialities
  • PODD Medical/Dental Instruments
  • Sector
  • DGX Health Care
  • PODD Health Care
  • Exchange
  • DGX Nasdaq
  • PODD Nasdaq
  • Market Cap
  • DGX 20.5B
  • PODD 22.1B
  • IPO Year
  • DGX 1996
  • PODD 2007
  • Fundamental
  • Price
  • DGX $187.93
  • PODD $333.21
  • Analyst Decision
  • DGX Buy
  • PODD Strong Buy
  • Analyst Count
  • DGX 15
  • PODD 18
  • Target Price
  • DGX $194.07
  • PODD $354.17
  • AVG Volume (30 Days)
  • DGX 1.2M
  • PODD 558.2K
  • Earning Date
  • DGX 10-21-2025
  • PODD 11-06-2025
  • Dividend Yield
  • DGX 1.71%
  • PODD N/A
  • EPS Growth
  • DGX 14.49
  • PODD N/A
  • EPS
  • DGX 8.51
  • PODD 3.45
  • Revenue
  • DGX $10,850,000,000.00
  • PODD $2,521,800,000.00
  • Revenue This Year
  • DGX $12.37
  • PODD $29.32
  • Revenue Next Year
  • DGX $3.51
  • PODD $18.37
  • P/E Ratio
  • DGX $21.96
  • PODD $96.41
  • Revenue Growth
  • DGX 13.74
  • PODD 27.11
  • 52 Week Low
  • DGX $148.70
  • PODD $230.05
  • 52 Week High
  • DGX $197.55
  • PODD $353.50
  • Technical
  • Relative Strength Index (RSI)
  • DGX 59.15
  • PODD 59.08
  • Support Level
  • DGX $184.50
  • PODD $311.51
  • Resistance Level
  • DGX $190.47
  • PODD $341.03
  • Average True Range (ATR)
  • DGX 4.23
  • PODD 11.79
  • MACD
  • DGX 1.14
  • PODD 1.86
  • Stochastic Oscillator
  • DGX 75.99
  • PODD 84.08

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: